Titelia

Holdings of Eventide Healthcare & Life Sciences Fund

MUTUAL FUND SERIES TRUST · 59 declared positions · as of Mar 31, 2026

Original filing · Net assets 1.6B $ · Ten largest lines: 35.5 % of the equity sleeve

Sector breakdown

  • Unattributed 100.0 %

Sector is not declared in Form N-PORT: this is a Titelia classification, decided company by company. The unattributed share is counted as such rather than spread over the others.

Currency breakdown

  • USD 100.0 %

The currency each line is denominated in, as declared. It does not follow the country: a French company listed in the United States is declared in dollars.

Country breakdown

  • US 87.9 %
  • NL 2.6 %
  • FR 2.6 %
  • CH 2.4 %
  • CA 2.1 %
  • BM 2.0 %
  • KY 0.3 %

Shares computed on the equity sleeve, the only part this site carries.

CountryLinesValueShare
US501.2B $87.89 %
NL135.9M $2.63 %
FR135.7M $2.61 %
CH232.8M $2.40 %
CA329.2M $2.14 %
BM127.3M $1.99 %
KY14.6M $0.34 %

Positions

CompanySharesValueWeight
Guardant Health Inc 700,32164.7M $4.07 %
Mirum Pharmaceuticals Inc 690,84663.8M $4.02 %
Insmed Inc 367,18360M $3.78 %
Kymera Therapeutics Inc 626,00052.1M $3.28 %
Vaxcyte Inc 827,52148.1M $3.03 %
Apogee Therapeutics Inc 557,42346.9M $2.96 %
Ionis Pharmaceuticals Inc 575,00043.2M $2.72 %
Argenx SE 49,19335.9M $2.26 %
Abivax SA 320,31135.7M $2.25 %
Scholar Rock Holding Corp 718,80735.3M $2.23 %
Celldex Therapeutics Inc 1,037,00032.9M $2.07 %
IRhythm Holdings Inc 277,73932.8M $2.06 %
Bridgebio Pharma Inc 437,13032.5M $2.04 %
Cytokinetics Inc 479,02831.6M $1.99 %
Trevi Therapeutics Inc 2,622,30631.3M $1.97 %
Palvella Therapeutics Inc 231,48428.9M $1.82 %
Celcuity Inc 242,87327.7M $1.75 %
Kestra Medical Technologies Ltd 1,368,13627.3M $1.72 %
Axsome Therapeutics Inc 159,15126.9M $1.69 %
MBX Biosciences Inc 890,00026.6M $1.67 %
CENTESSA PHARMACEUTICALS PLC 668,14226.5M $1.67 %
Sionna Therapeutics Inc 644,52425.8M $1.63 %
Disc Medicine Inc 395,23525.3M $1.59 %
Revolution Medicines Inc 257,21825M $1.58 %
CG oncology Inc 366,39724.8M $1.56 %
Immix Biopharma Inc 2,549,01923.2M $1.46 %
Arrowhead Pharmaceuticals Inc 370,00023.2M $1.46 %
Evommune Inc 940,11921.6M $1.36 %
ADC Therapeutics SA 5,701,65521.4M $1.35 %
Amylyx Pharmaceuticals Inc 1,512,44421M $1.32 %
Beta Bionics Inc 2,052,17620.6M $1.30 %
Nurix Therapeutics Inc 1,297,89320.1M $1.27 %
Dianthus Therapeutics Inc 225,26118.9M $1.19 %
Sutro Biopharma Inc 715,30717.8M $1.12 %
HeartFlow Inc 714,37117.4M $1.09 %
United Therapeutics Corp 28,24316.7M $1.05 %
EyePoint Inc 1,245,58316.1M $1.01 %
Dexcom Inc 252,61115.9M $1.00 %
GeneDx Holdings Corp 243,14415.6M $0.98 %
OVID THERAPEUTICS INC 7,021,31815.6M $0.98 %
Glaukos Corp 142,69215.4M $0.97 %
Privia Health Group Inc 737,69415.2M $0.96 %
Definium Therapeutics Inc 686,16213M $0.82 %
Praxis Precision Medicines Inc 38,30712.3M $0.78 %
ORIC Pharmaceuticals Inc 951,43312.1M $0.76 %
Invivyd Inc 9,071,99511.8M $0.74 %
Oculis Holding AG 430,00011.4M $0.72 %
Bright Minds Biosciences Inc 130,0139.5M $0.60 %
Castle Biosciences Inc 386,4259.5M $0.60 %
Aktis Oncology Inc 507,0009.1M $0.57 %
TransMedics Group Inc 82,6288.2M $0.52 %
Corvus Pharmaceuticals Inc 550,0008M $0.51 %
Cybin Inc 1,410,8156.8M $0.43 %
Ovid therapeutics Inc 2,895,5936.4M $0.40 %
Evolent Health Inc 2,547,5585.8M $0.37 %
Edgewise Therapeutics Inc 149,8634.7M $0.30 %
Belite Bio Inc 29,0264.6M $0.29 %
CytomX Therapeutics Inc 900,0004.2M $0.27 %
Collegium Pharmaceutical Inc 63,6592.1M $0.13 %